• 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2020-03
  • 2020-07
  • 2020-08
  • 2021-03
  • br Wilson R Spiller DG Prior IA Bhatt


    [30] Wilson R, Spiller DG, Prior IA, Bhatt R, Hutchinson A. Magnetic microspheres encoded with photoluminescent quantum dots for multiplexed detection. J Mater Chem 2007;17:4400–6.
    [32] Labiadh H, Chaabane TB, Sibille R, Balan L, Schneider R. A facile method for the preparation of bifunctional Mn:ZnS/ZnS/Fe3O4 magnetic and fluorescent nanocrystals. Beilstein J Nanotechnol 2015;6:1743–51.
    [33] Yang J, Lee J, Kang J, Chung CH, Lee K, Suh JS, Yoon HG, Huh YM, Haam S. Magnetic sensitivity enhanced novel fluorescent magnetic silica nanoparticles for biomedical applications. Nanotechnology 2008;19:075610.
    [34] Ahmed SR, Dong J, Yui M, Kato T, Lee J. Quantum dots incorporated magnetic nanoparticles for imaging colon carcinoma cells. J Nanobiotechnol 2013;11:28.
    [35] Petronzelli F, Pelliccia A, Anastasi AM, Lindstedt R, Manganello S, Ferrari LE, Albertoni C, Leoni B, Rosi A, D’Alessio V, Deiana K, Paganelli G, Santis RD. Therapeutic use of avidin is not hampered by antiavidin 13(S)-HODE in humans. Cancer Biother Radiopharm 2010;25:563–70. 
    [36] Chinol M, Casalini P, Maggiolo M, Canevari S, Omodeo ES, Caliceti P, Veronese FM, Cremonesi M, Chiolerio F, Nardone E, Siccardi AG, Paganelli G. Biochemical modifications of avidin improve pharmacokinetics and biodistri-bution,and reduce immunogenicity. Br J Cancer 1998;78:189–97.
    [37] Yumura K, Ui M, Doi H, Hamakubo T, Kodama T, Tsumoto K, Sugiyama A. Mu-tations for decreasing the immunogenicity and maintaining the function of core streptavidin. Protein Sci 2013;22:213–21.
    [38] Posern G, Zheng J, Knudsen BS, Kardinal C, Müller KB, Voss J, Shishido T, Cow-burn D, Cheng G, Wang B, Kruh GD, Burrell SK, Jacobson CA, Lenz DM, Zam-borelli TJ, Adermann K, Hanafusa H, Feller SM. Development of highly selec-tive SH3 binding peptides for Crk and CRKL which disrupt Crkcomplexes with DOCK180, SoS and C3G. Oncogene 1998;16:1903–12.
    [40] Reinke AW, Grant RA, Keating AE. A synthetic coiled-coil interactome pro-vides heterospecific modules for molecular engineering. J Am Chem Soc 2010;132:6025–31.
    [41] Alexis F, Basto P, Levy-Nissenbaum E, Radovic-Moreno F, Zhang L, Pridgen E, Wang AZ, Marein SL, Westerhof K, Molnar LK, Farokhzad OC. HER-2-targeted nanoparticle-a body bioconjugates for cancer therapy. ChemMedChem 2008;3:1839–43.
    [42] Canine BF, Wang Y, Hatefi A. Biosynthesis and charcterization of a novel genet-ically engineered polymer for targeted gene transfer to cancer cells. J Control Release 2009;138:188–96.
    [43] Puri A, Kramer-Marek G, Campbell-Massa R, Yavlovich A, Tele SC, Lee SB, Clogston JD, Patri AK, Blumenthal R, Capala J. HER2-specific a body-conju-gated thermosensitive liposomes (a somes) for improved delivery of anti-cancer agents. J Liposome Res 2008;18:293–307.
    [44] Chang CH, Cheng WJ, Chen SY, Kao MC, Chiang CJ, Chao YP. Engineering of Escherichia coli for targeted delivery of transgenes to HER2/neu-positive tumor cells. Biotechnol Bioeng 2011;108:1662–72.
    Contents lists available at ScienceDirect
    Pharmacological Research
    journal homepage:
    A thermo-responsive alginate nanogel platform co-loaded with gold nanoparticles and cisplatin for combined cancer chemo-photothermal therapy 
    Mehri Mirrahimia,b, Ziaeddin Abeda,b, Jaber Beika,b, Isaac Shiric, Amin Shiralizadeh Dezfulia, Vahid Pirhajati Mahabadid,e, S. Kamran Kamravaf, Habib Ghaznavig, , Ali Shakeri-Zadeha,b,f,
    a Finetech in Medicine Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran
    b Medical Physics Department, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran